Orca Surgical

Company Overview

Snapshot

Founded in January 2012 by Yariv Bar On, Orca Surgical operates with 1–10 employees. The company holds a patent and is recognized for its Epi-Bowmans Keratectomy (EBK) procedure, a new treatment paradigm for laser refractive surgery.

Business overview

Orca Surgical develops advanced solutions for refractive ophthalmologic surgery, addressing conditions such as keratoconus, refractive enhancement, and recurrent corneal erosions. Its core technology centers on the Epi-Bowmans Keratectomy (EBK) procedure, which utilizes the Epi Clear device, a single-use polymer epikeratome designed for precise epithelial surface removal. This procedure aims to expedite patient recovery and reduce pain during epithelial healing by creating clear borders that augment epithelial periphery growth. The company's products, including EBK Clear, EBK Cross, and EBK, are Class 1 exempt, CE, and AMAR approved, serving hospitals and clinics in the United States and Europe within the Health Tech & Life Sciences sector.

Strategic signal

In January 2026, Orca Surgical was noted in news regarding the definitive close of a two-year legal dispute between Israeli cloud security rivals. This event signals the company's operational resilience and ability to navigate complex external challenges, which is crucial for investor confidence in its long-term stability and focus on its core medical device innovations.

Company Intelligence Q&A

What is Orca Surgical's primary focus in ophthalmology?

Orca Surgical focuses on developing solutions for refractive surgery, keratoconus, refractive enhancement, and recurrent erosions of the cornea.

What is the Epi-Bowmans Keratectomy (EBK) procedure?

The EBK procedure is a new treatment paradigm for laser refractive surgery developed by Orca Surgical, designed to remove the epithelium safely, quickly, and painlessly, providing a treatment bed for various applications and expediting patient recovery.

What device is central to the EBK procedure?

The EBK procedure is based on the Epi Clear device, a single-use polymer epikeratome designed for precise epithelial surface removal, which gently sweeps the epithelial surface and collects discarded cells.

What certifications do Orca Surgical's products hold?

Orca Surgical's products are Class 1 exempt, manufactured according to international standards, and are CE and AMAR approved.

What was a notable legal development for Orca Surgical in early 2026?

In January 2026, a two-year legal feud between Israeli cloud security rivals, which Orca Surgical was involved in, came to a definitive close.